Givaudan, a global leader in taste and wellbeing, is proud to announce that it has received an award for LifenolTM, a clinically proven and patented hops extract for menopause symptoms, at the Vitafoods Europe Innovation Awards, held on 20 May in Barcelona. The award highlights Givaudan’s leadership in delivering scientifically backed, botanical ingredients, which contribute to outstanding wellness experiences for consumers globally.
Stephane Dupuits, Head of the Health & Functional Business Unit, Givaudan said, “We’re delighted to win this award for LifenolTM, our science-backed hops extract that supports women’s health as they age. It reflects our commitment to deliver effective and trusted health solutions that taste great and support proactive health and wellbeing.”
Lifenol™ has been proven in gold-standard clinical trials to relieve uncomfortable menopausal symptoms, such as hot flashes, while also supporting total bone-mineral density. Lifenol™ offers scientifically-substantiated benefits for menopause. It’s a natural way to improve menopausal quality of life.
Lifenol™ is a natural, low-dose solution delivering effective phytoestrogen, prenylnaringenin (8-PN). A single 85mg dose has been clinically shown to alleviate distressing menopausal symptoms such as hot flashes and sleep problems in 2 separate studies. ² ³ It is also clinically demonstrated to support bone health.
For more information, visit the Givaudan Health Solutions Hub